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ABSTRACT
We have previously shown that clusters of guanine
quadruplex (G4) structures can form in the human
herpes simplex-1 (HSV-1) genome. Here we used im-
munofluorescence and immune-electron microscopy
with a G4-specific monoclonal antibody to visualize
G4 structures in HSV-1 infected cells. We found that
G4 formation and localization within the cells was
virus cycle dependent: viral G4s peaked at the time
of viral DNA replication in the cell nucleus, moved
to the nuclear membrane at the time of virus nuclear
egress and were later found in HSV-1 immature viri-
ons released from the cell nucleus. Colocalization
of G4s with ICP8, a viral DNA processing protein,
was observed in viral replication compartments. G4s
were lost upon treatment with DNAse and inhibitors
of HSV-1 DNA replication. The notable increase in
G4s upon HSV-1 infection suggests a key role of
these structures in the HSV-1 biology and indicates
new targets to control both the lytic and latent infec-
tion.
INTRODUCTION
Guanine-rich DNA sequences can form stable four-
stranded guanine quadruplex (G4) structures based on
the formation of G-quartets, which are stabilized by
Hoogsteen-type hydrogen bonds between guanines and
monovalent cations between the G-quartets (1).
In eukaryotes, G4s have been shown to occur in function-
ally important regions of the genome: in telomeres, G-rich
micro- and mini-satellites, within promoters, and in riboso-
mal DNA (rDNA) repeat arrays (2–4). Human DNA G4
motifs have been reported to be associated with recombina-
tion prone regions (5) and to show mutational patterns that
preserved the potential to form G4 structures (4,6).
The presence of G4 DNA structures in human cells has
recently been supported by specific antibodies derived from
phage display selection (7) and hybridoma technology (8).
Besides eukaryotes, G4 relevance and presence have re-
cently emerged also in prokaryotes (9,10) and viruses (11).
The presence of functionally significant G4 DNA motifs
in the human immunodeficiency virus (HIV) has been re-
ported by us and others both in the promoter (12–14) and
Nef coding regions (15). The herpes simplex virus-1 (HSV-
1) genome has a very highGC content (68%) which peaks at
84.7% GC in simple sequence repeats (SSRs) (16). Recently
we provided evidence for the presence of very stable G4-
forming regions located in the HSV-1 inverted repeats (17).
In particular, multiple conserved and extended clusters of
G4 forming sequences were observed, covering about 2,000
bp of the 152,000 bp-viral genome.
HSV-1 first lytic infection occurs within mucosal epithe-
lial cells, where the expression of viral genes proceeds in a
regulated cascade in which three classes of viral genes are
temporally expressed: immediate-early (IE), early (E) and
late (L) (18). The virus next enters sensory neurons where
latency is established; it can later reactivate resulting in the
generation of new virions that cause recurrent disease (19).
Both in the case of HSV-1 and HIV-1, treatment of in-
fected cells withG4 ligands greatly impaired viral infectivity
(13,15,17); in particular, treatment with BRACO-19 stabi-
lized G4s in the HSV-1 genome and inhibited viral replica-
tion (17).
Given the extraordinary extension of G4 forming regions
in the HSV-1 genome, we here aimed at visualizing G4s
in eukaryotic cells infected with HSV-1. By employing the
anti-G4monoclonal antibody 1H6 (8), wewere able to show
strong enrichment of G4 structures in cells upon infection.
G4 formation depended on the viral cycle, with the high-
est G4 signal observed at the time of viral replication. The
observed G4s mainly localized in viral replication compart-
ments (RCs) and treatment with viral DNA polymerase in-
hibitors greatly decreased the G4 antibody signal.
MATERIALS AND METHODS
Cells and viruses
Vero cells (Sigma Aldrich, Milan, Italy) and TZM-bl re-
porter cell line (obtained through the NIH AIDS Reagent
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Program, Division of AIDS, NIAID,NIH, from Dr J.C.
Kappes, Dr X. Wu and Tranzyme Inc.) were grown in Dul-
becco’s modified Eagle medium supplemented with 10% fe-
tal bovine serum (FBS) and PenStrep 1× (Life Technolo-
gies, Monza, Italy). Wild-type (wt) HSV-1 strain F was a
kind gift fromBernardRoizman (University of Chicago, IL,
USA), recombinant HSV-1 expressing VP16-GFP (HSV-1
v41) was kindly provided by Peter O’Hare (Imperial College
London,UK) (20). For virus infection, wt ormutant viruses
were incubated with cells at different multiplicities of infec-
tion (MOI) in serum-free medium. After 1 h of incubation
at 37◦C, the inoculum was replaced with complete medium.
Mock-infected cells were treated in the exact same way ex-
cept that serum-freemediumwas added in place of the virus.
HIV-1NL4-3 stock was prepared transfectingHEK293Twith
the proviral genome (NIH AIDS Reagent Program, Divi-
sion ofAIDS,NIAID,NIH, fromDrMalcolmMartin). For
HIV-1 infection, TZM-bl cells were infected with wt virus at
differentMOIs. After 2 h, cells were washed with phosphate
buffered saline (PBS) 1× and grown in complete medium.
Antibodies and immunofluorescence
The mouse monoclonal 1H6 antibody has been previously
reported (8,21). The rabbit 3–83 antiserum specific for ICP8
was a kind gift from David M. Knipe (Harvard Medical
School, Boston, USA) (22) anti-HSV-1 ICP8 monoclonal
antibody conjugated with FITC was obtained from Santa
Cruz Biotechnology Inc.
For immunofluorescence studies, Vero or TZM-bl cells
were seeded at 5× 104 cells/well in 8-well plates (8-well cul-
tureslide, BD Falcon™) or at 0.5-1 × 105 cells/well on glass
12-mm-diameter coverslips in 24-well plates and grown
overnight at 37◦C. Following infection at multiple MOIs
(from 0.5 to 8) and incubation for an appropriate time (from
2 to 20 h.p.i. or 24 h.p.i. forHIV-1 infection), cells were fixed
in 4% paraformaldehyde (PFA, Sigma Aldrich) in PBS 1×
for 20 min at room temperature (rt) and permeabilized with
0.5% Tween-20 (Sigma Aldrich) in PBS 1×. After block-
ing in PBS containing 5% of FBS, cells were incubated with
1H6 antibody at 1 g/ml for 2 h at rt, rinsed with PBS-
T (0.2% Tween-20 in PBS 1×) and incubated with Alexa
Fluor-546 goat anti-mouse IgG at 1:500 (Molecular Probes,
Life Technologies) for 1 h at rt and, where needed, followed
by 1 h incubation at rt with FITC-conjugated anti-HSV-1
ICP8 at 1:200 or anti-ICP8 serum at 1:1000 dilution and
Alexa Fuor-488 goat anti-rabbit IgG at 1:500 (Molecular
Probes, Life Technologies) for 30 min. Nuclei were stained
with far-red fluorescent DNA dye (DRAQ5®, 1:1000, Cell
Signaling Technology, USA) for 5 min at rt. For enzyme
treatment, Vero cells were incubated with 50 g/ml RNase-
A (Thermo Scientific) in PBS 1× or 0.12 U/l DNAse
I (Life Technologies) in saline buffer 1× (100 mM Tris
pH = 7.5, 25 mM MgCl2, 5 mM CaCl2) for 1 h at 37◦C,
then blocked with FBS and stained with antibodies as de-
scribed above. Mock-infected cells were treated in the ex-
act same way as infected cells in each type of experiment
and staining, except that serum-free medium was added
in place of the virus. For viral replication inhibition, cells
were treated with 400 g/ml phosphonoacetic acid (PAA)
(Sigma Aldrich) or acyclovir (ACV) (100 M) from 1 h be-
fore infection up to fixation. For fluorescence quantification
experiments, images were acquired using a Nikon A1Rsi+
Laser Scanning confocal microscope equipped with NIS-
Elements Advanced Research software (Nikon Instruments
Inc., Melville, USA), with 20× and 60× ocular objectives.
Laser excitation and emission filters were: blue laser at
488 nm, emission filter 500–550 nm; yellow-green laser at
561 nm, emission filter 570–620 nm; red laser at 640 nm,
emission filter 663–738 nm. Excitation and emission wave-
length at the maximum peak and emission color of the fluo-
rophores used in this work were: DAPI 358–461 nm––blue;
FITC 490–525 nm––green; Alexa Fluor®488 496–519
nm––green; GFP 488–509 nm––green; Alexa Fluor®546
556–573 nm––orange; DRAQ5® 646–681/697 nm––red.
To achieve constant quantification circumstances and to
maintain high reproducibility of the data, FocalCheck™
Fluorescent Microsphere Standards (Life Technologies,
Italy) were used to set the Confocal Laser Scanning Mi-
croscopy (CLSM) unit calibration parameters. For quantifi-
cation, overall fluorescence intensity detected by the micro-
scope software at 20× (Figure 2C and Supplementary Fig-
ure S2) was normalized for the total number of G4-positive
cell nuclei. All samples were further normalized for the to-
tal number of cells and divided by the mock sample sig-
nal, which was set to 100%. Cells were counted using Im-
ageJ software; at least three pictures per condition (200–
500 cells/picture) were considered. Colocalization analysis
from 3D acquisitions was acquired using the NIS-Elements
Advanced Research software. Final images included in this
work are representative of multiple experiments. For each
repetition, mock-infected cells and at least one reference
time point of viral replication were included for compari-
son. All viral conditions were assayed at least three times.
Surface plasmon resonance (SPR) analysis
Surface plasmon resonance (SPR) was performed on
the Biacore T100 platform (GE Healthcare, Life Sci-
ence, Milan, Italy). The following oligonucleotides
were used (Sigma-Aldrich, Milan, Italy): gp054a 5′-
GGGGTTGGGGCTGGGGTTGGGG-3′; un2 5′-
GGGGGCGAGGGGCGGGAGGGGGCGAGGGG-3′;
un3 5′-GGGAGGAGCGGGGGGAGGAGCGGG-
3′; Oxy2 5′-TTTTGGGGTTTTGGGG-3′; OxyTel
5′-GGGGTTTTGGGGTTTTGGGGTTTTGGGG-
3′; hTel21 5′-GGGTTAGGGTTAGGGTTAGGG-3′;
hTel22 5′-AGGGTTAGGGTTAGGGTTAGGG-3′;
hTel54 5′-TCGAGGGTTAGGGTTAGGGTTAGGGT
TAGGGTTAGGGTTAGGGTTAGGGTTAC-3′; bcl-2
5′-GGGCGCGGGAGGAAGGGGGCGGG-3′; c-myc
5′-TGGGGAGGGTGGGGAGGGTGGGGAAGG-3′; c-
kit1 5′-AGGGAGGGCGCTGGGAGGAGGG-3′; c-kit2
5′-CGGGCGGGCGCGAGGGAGGGT-3′;
hTelScra 5′-GGATGTGAGTGTGAGTGTGAGG-3′;
LTRScra 5′-TTTTTGGAGCGTGTGTGCGCGAGA
GCGTGCGCGTGGCGAGCGTTGAGTGGTTTTT-
3′; rnd 5′-AAAAACTACTGCACGCTCGCTACGAC
GACACTGTCGCGCATACAAGCTGCAAAAA-3′
(Random in (23)); T9 5′-TTTTTTTTT-3′; T30 5′-
TTTTTTTTTTTTTTTTTTTTTTTTTTTTTT-3′; hp
5′-CGCAGCGTGGCTTTGTTTGCCACGCTGCG-
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3′; dsDNA: hTelScra+complementary sequence;
NRAS RNA 5′-GGGAGGGGCGGGUCUGGG-
3′; U3-III HIV RNA 5′-GGGAGGCGUGGCCU
GGGCGGGACUGGGG-3′; U3-IV HIV RNA 5′-
GGGCGGGACUGGGGAGUGG-3′; hTel2 RNA
5′-UAGGGUUAGGGU-3′; TAR HIV RNA 5′-
GGCAGAUCUGAGCCUGGGAGCUCUCUGCC-3′;
rnd RNA 5′-GAGCGUGCGCGUGCGAGCGUGAGU
GAGCGUGGG-3′. To allow the correct orientation of
1H6 binding site on the chip, 1H6was incubated for 1 h at rt
in the presence of the G4-folded un3. The Mouse Antibody
Capture kit (GEHealthcare, Life Science, Milan, Italy) was
next used to capture 1H6-un3 complex on Serie S sensor
chip CM5. Immobilization of the anti-mouse IgG (GE
Healthcare, Life Science, Milan, Italy) was performed by
amine coupling in HEPES-NaCl running buffer (HEPES
pH 7.4 10 mM, NaCl 150 mM, ethylenediaminetetraacetic
acid (EDTA) 3 mM), while 1H6-un3 capturing was per-
formed in HEPES-KCl buffer (HEPES 10 mM, KCl 200
mM, EDTA 3 mM). Un3 was dissociated with a flow
of HEPES-KCl buffer followed by injection of KCl 1M.
Flow cell 1 was blank immobilized with anti-mouse IgG to
permit reference subtraction. Folding of oligonucleotides
into G4s was performed in HEPES-KCl buffer after heat
denaturation at 95◦C for 5 min and gradual cooling at room
temperature. Binding analysis of each oligonucleotide was
performed at a flow rate of 20 l/min, with contact time
of 340 sec and dissociation time of 240 sec in HEPES-KCl
buffer. Sensorgrams were obtained in the concentration
range of 0.25-8 M. After each oligonucleotide injection,
the chip surface was regenerated with KCl 1M solution.
All sensorgrams were corrected by reference subtraction
of blank flow cell response and buffer injection response.
Data were fitted to a global 1:1 binding model using
BIAevaluation software (GE Healthcare). The stability of
1H6 binding was evaluated by measuring RU response 20
sec before end of the dissociation phase.
Flow cytometry analysis
For FACS analysis, Vero cells were seeded at 2 × 106
cells/dish in 10-cm-dishes (BD Falcon™), grown overnight
at 37◦C and infected with HSV-1 v41 at a MOI of 0.5 as de-
scribed above. At 8 h.p.i., cells were washed with PBS 1×
and fixed in IC Fixation Buffer (eBiosciences, CA, USA).
HSV-1 infected cells were incubated with 1H6 antibody in
permeabilization buffer 1× (eBiosciences) for 1 h, followed
by incubation with secondary antibody Alexa Fluor-633
goat anti-mouse at 1:500 (Molecular Probes, Life Technolo-
gies). All incubations were carried out at rt, according to the
manufacturer’s instructions. Mock-infected Vero cells were
treated as infected cells and used as negative control. A to-
tal of 30,000 events/sample were acquired with a LRS 2 in-
strument using FACS DIVA Software (BD Bioscience, San
Jose, CA, USA) and analyzed with FlowJo (Tree Star, OR,
USA).
Immuno-electron microscopy (Immuno-EM)
Vero cells were seeded at 1 × 105 cells/well in 12-well plates
and grown overnight at 37◦C. Immuno-EM samples were
prepared as previously described (21). At 8 and 15 h.p.i.,
cells infected with wt HSV-1 at MOI 5 were washed with
PBS 1× and fixed in 2.5% glutaraldehyde buffered in 0.1
M cacodylate buffer (Sigma Aldrich) for 1 h at 4◦C. Cells
were washed with 0.1 M cacodylate buffer, post-fixed in 1%
OsO4/1.5%K3Fe(CN6) for 30–60 min, dehydrated and em-
bedded in epoxy resin according to standard protocols. Sec-
tions were collected on nickel grids, treated with 1% peri-
odic acid (Sigma Aldrich) for 20 min at rt, rinsed with dis-
tilled water and blocked in blocking buffer (Tris-buffered
saline (TBS) containing 1% bovine serum albumin, 0.1%
glycine, 0.1% cold water fish skin gelatin and 5% FBS).
Grids were incubated overnight with 1H6 and rabbit 3–83
anti-ICP8 serum, followed by incubation for 2 h at rt with
anti-mouse secondary antibody conjugated to 5-nm gold
(Sigma Aldrich) at 1:100 or anti-rabbit secondary antibody
conjugated to 10-nm gold (Sigma Aldrich) at 1:100, respec-
tively. Samples were rinsed with distilled water and con-
trasted with uranyl acetate and lead citrate. Images were
collected with a FEI Tecnai G12. For statistical analysis,
the number of G4 and ICP8 dots in 35–45 images per con-
dition was counted with the aid of ImageJ software. The
number of recorded dots was calculated on the total images
area (mm2) ± SEM. The frequency of G4s in virions was
calculated as the number of G4 dots in virions on the num-
ber of virions in samples treated with 1H6 (41 images) and
compared to the number of dots in virions/number of viri-
ons in the negative control treated only with the secondary
Ab (38 images). The Student’s t-test was used to calculate
the statistical significance.
RESULTS
The monoclonal antibody 1H6 binds with high efficiency to
HSV-1 G4-forming sequences
We have previously shown that at least four G-rich repeated
sequences in the HSV-1 genome can fold into G4 struc-
tures in vitro (17). Three sequences feature four GGGG-
tracts, while one sequence has four GGG-tracts, displaying
the ability to form multiple monomolecular 4- or 3-tetrad
stacked G4, respectively (Table 1).
Since the anti-G4 1H6 antibody (Ab) has been reported
to have broad specificity for many but not all G4 struc-
tures (8), we initially tested its affinity for the selected HSV-
1 G4-forming sequences in vitro by SPR. Three HSV-1 se-
quences were tested: un2 (antiparallel), un3 (parallel) and
gp054a (mixed-type); un1 could not be tested because unsta-
ble in solution (17). A series of control sequences was along-
side tested: the tetramolecular Oxytrichia telomeric G4,
which 1H6 was developed against (Oxy2), the monomolec-
ular Oxytrichia G4 (OxyTel), three different-length human
telomeric G4s (hTel21, hTel22 and hTel54), four G4s of
oncogene promoters (bcl-2, c-myc, c-kit1, c-kit2) (24–27),
two G-rich oligonucleotides corresponding to the scram-
bled sequences of the human telomeric and HIV-1 LTR
promoter G4s (hTelScra and LTRScra) (13,15,17), one ran-
dom ssDNA (rnd), two polyTs (T9 and T30), one hairpin
oligonucleotide (hp) and a dsDNA. RNA sequences were
also tested, in particular: two cellular G4s found in the 5′-
UTRof the transcript of the humanNRASproto-oncogene
(NRAS) (28) and in telomeric transcripts (hTel2) (29), two
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Table 1. HSV-1 G4-forming sequences described in (17).
HSV-1 sequences Sequence (5′ → 3′)
gp054 GGGGXTGGGGXTGGGGXTGGGG
un1 GGGGGAGAGGGGAGAGGGGGGGAGAGGGG
un2 GGGGGCGAGGGGCGGGAGGGGGCGAGGGG
un3 GGGAGGAGCGGGGGGAGGAGCGGG
X indicates T or C. G-tracts are underlined.
G4s that form in the HIV-1 RNA genome (U3-III and U3-
IV) (30); one hairpin RNA from the HIV transcript (TAR)
(31) and one unstructured random RNA (rndR). The ab-
solute binding affinity at the thermodynamic equilibrium
could be obtained only for few of these sequences. In par-
ticular, Oxy2 displayed the best affinity (KD 62.0± 4.2 nM);
hTel54 had a 10-fold lower affinity (KD 654.5 ± 70.7 nM),
slightly lower than un2, un3 and NRAS RNA (KD 535.3 ±
20.5, 479.7± 14.1 nMand 539.2± 16.2, respectively); gp054
was three times a lesser good binder than un2 (KD 1.67 ±
0.46 M). The other sequences displayed either no or un-
specific interaction with 1H6 (Supplementary Figure S1).
KD values represent the binding affinity at the equilibrium.
However, other kinetic parameters can be obtained by SPR,
such as the binding stability (32). To compare all tested se-
quences, we measured the stability of 1H6/oligonucleotide
right before the end of the dissociation phase, which can
be roughly compared to the final wash step in an ELISA
assay (8). In these conditions, for the DNA sequences, the
best stabilization was again obtained with Oxy2, un2 and
un3 sequences (Figure 1); gp054, hTel54, hTel21, OxyTel,
bcl-2, c-myc, c-kit1 and c-kit2 (all G4 forming sequences)
also showed stabilization though to a lower extent; hTel22
and all non-G4-forming oligonucleotides displayed no sta-
bilization (Figure 1). For the RNA sequences, NRAS G4
displayed stabilization similar to that of un3; all other se-
quences displayed very low or non-significant stabilization
(Figure 1). These data indicate that two of the three tested
HSV-1 G4s are bound at least 30 times better than ssDNA.
Interestingly, un2 and un3 are the most abundant repeats in
all HSV-1 strains (17). The SPR data also indicate the excel-
lent G4 selectivity of 1H6, which recognizes G4s with dif-
ferent efficiency, depending on the conformation, and does
not bind unstructured oligonucleotides.
G4 formation in infected cells depends on the HSV-1 cycle
and peaks during viral replication
Based on the above encouraging data, showing that 1H6Ab
binds with high efficiency HSV-1 G4s versus most other cel-
lular G4s and non-structured sequences possibly present in
a mammalian cell, we proceeded using 1H6 to visualize G4s
in HSV-1 infected cells. To this end, HSV-1 susceptible cells
(Vero) were infected with HSV-1 v41, a recombinant virus
expressing the viral protein VP16 fused to the green fluo-
rescent protein (GFP). This mutant virus is characterized
by normal replication kinetics and yields (20). VP16 is an
essential and abundant L tegument protein that regulates
IE gene transcription, assembly and viral egress. VP16-GFP
is normally incorporated into the virion, resulting in fluo-
rescent particles, which allow monitoring of viral steps in
infected cells (20,33). In general, no significant VP16-GFP
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Figure 1. SPR analysis of 1H6 antibody binding stability to HSV-1
G4-forming oligonucleotides and control sequences. HSV-1 G4-forming
oligonucleotides (un2, un3, gp054a) (Table 1) and the controls (0.25-8 M)
were injected on chip-immobilized 1H6. The binding stability values at 4
M oligonucleotides are shown. Values were measured in the late dissoci-
ation phase. For DNA sequences: Oxy2 forms a tetramolecular G4 against
which 1H6 was initially developed in animals; OxyTel is the correspond-
ing monomolecular G4. HTel21, hTel22 and hTel54 are different-length
G4-forming telomeric repeats; bcl-2, c-myc, c-kit1 and c-kit2 are onco-
gene promoter G4s; hTelScra and LTRScra are G-rich non-G4-forming
oligonucleotides; rnd is a random sequence; T9 andT30 are polyT oligonu-
cleotides; hp is a hairpin forming sequence; dsDNA is double stranded
DNA. For RNA sequences: NRAS and hTel2 are two cellular G4s; U3-III
and U3-IV are two HIV-1 G4s; TAR is a hairpin RNA; rndR is a unstruc-
tured random RNA. Results are shown as RU (response units) values ±
SEM (n = 3).
signal is detectable at the earliest stages of infection (up to
3 h.p.i.), whereas between 3 and 5–6 h.p.i. newly synthe-
sized VP16-GFP becomes visible in punctate foci diffused
in the nucleus. At 7 to 12 h.p.i., VP16-GFP is also detected
in the cytoplasm. After 12 h.p.i., VP16-GFP accumulates in
vesicular-like foci mainly in the cytoplasm. At late stages,
accumulation of high signal intensity VP16-GFP occurs at
the boundaries between cells (20,33). G4s, VP16-GFP and
DNAwere visualized at different times post-infection (p.i.),
including pre-replication (2-4 h.p.i), replication (6-9 h.p.i.)
and post-replication events (14-20 h.p.i.), to fully comprise
a single cycle of replication (34).
The VP16-GFP signal steadily increased from 2–5 h.p.i.,
when it was just above background levels and localized in
the nucleus, to 6–20 h.p.i. when it sharply increased and lo-
calized entirely in the cytoplasm (Figure 2A and Supple-
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Figure 2. Immunofluorescence confocal microscopy of HSV-1 v41-infected mammalian cells at 60×magnification. (A) Infected cells visualized at different
h.p.i., corresponding to a single cycle of replication. (B) Cells infected with increasing MOIs of HSV-1 v41 visualized at 6 h.p.i. and infected cell treated
with DNase, RNAse and PAA, an inhibitor of the viral DNA polymerase, visualized either at 6 h.p.i. or 20 h.p.i., as indicated. In all images: the red
signal indicates G4s, detected with the 1H6 primary Ab and Alexa Fluor-546 secondary Ab; the green signal derives from the viral recombinant L pro-
tein VP16-GFP and indicates the presence of the virus in cells; the blue signal is obtained staining the DNA with DRAQ5®. In the merge images the
blue signal is shown overlapped with the red and green fluorescence. Mock-infected cells were treated in the same conditions. Shown are representative
images at 60× magnification. Each condition was tested at least three times, always including mock-infected and infected cells as reference. Scale bars: 50
m. (C) Quantification of the G4 (1H6) signal. Data refer to intensity values supplied by the instrument for the non-saturated signal in the 20× images
(Supplementary Figure S2), opportunely normalized to the number of cell nuclei and to mock-infected cell fluorescence intensity. (D) Three-dimension
(3D) confocal microscopy of HSV-1 v41 infected cell at 15 h.p.i.. Red fluorescence indicates G4s (1H6), which are mainly localized at the internal layer
of the nuclear membrane; the green fluorescence shows the late viral protein VP16-GFP, mainly accumulated in the cytoplasm at this time p.i.; the blue
fluorescence shows the DNA dispersed in the cell nucleus. Scale bar: 10 m.
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mentary Figure S2), fully matching its previously reported
behavior (20) and representing a typical HSV-1 infection.
In these conditions, intensity of the G4 signal was barely
above that of mock-infected cells at 2–4 h.p.i. (4–10%), it
remarkably increased at 6–9 h.p.i. (50–80%), progressively
decreased at 14 h.p.i. (30–40%) and at 20 h.p.i. reverted to
signal just above that of mock-infected cells (10%) (Figure
2A, C and Supplementary Figure S2a). Negative controls,
i.e. infected and mock-infected cells lacking treatment with
primary antibodies and treated with secondary antibodies,
showed no unspecific background in these conditions (Sup-
plementary Figure S3). Quantitative flow cytometry anal-
ysis confirmed that the G4 signal in 1H6-stained cells at
8 h.p.i. increased by 57% compared to mock-infected cells
(Figure 3).
As for G4 localization, at 2–9 h.p.i. the G4 signal was
almost uniformly localized in the cell nucleus, with visible
bright punctate foci. Differently, at 14–20 h.p.i. the G4 sig-
nal gradually clustered to the nuclearmembrane (Figure 2A
and corresponding magnification in Supplementary Figure
S4). In particular, high-resolution 3D and 2D analysis (Fig-
ure 2D and Supplementary Figure S5, respectively) showed
that at 15 h.p.i. G4s (red signal) were clustered at the inter-
nal layer of the nuclear membrane, the DNA (blue signal)
was uniformly distributed within the cell nucleus, with por-
tions of it close to the nuclear membrane, and the viral pro-
tein (green signal) was dispersed in the cytoplasm. The nu-
clear membrane localization of viral G4s is in line with the
reported lateral diffusion of theHSV-1machinery, which al-
lows budding of the virus from the nucleus after viral DNA
replication has occurred (35,36). Cells infected with increas-
ing virus amounts (MOIs 1, 4, 8) displayed increased G4
signal (Figure 2B, C and Supplementary Figure S2b), in-
dicating that G4 formation was strictly dependent on the
amount of virus in the cell. Since 1H6 recognized one RNA
G4 in our SPR testing, to detect the nature of the visual-
ized G4s, infected cells were treated with DNase I or RNase
A: DNase-treated samples drastically reduced G4s to levels
below those of mock–infected cells, whereas treatment with
RNAse induced only aminor (20%) decrease inG4s (Figure
2B, C and Supplementary Figure S2c), which may account
for viral/cellular RNA G4s. As expected, VP16-GFP was
not affected by these treatments. These data indicate that
G4s visualized in infected cells are mainly DNA G4s.
Cells treated with PAA or ACV, two specific inhibitors of
the viral DNA polymerase, which replicates the viral DNA
at around 6–8 h.p.i. (17,37,38), displayed G4 signal simi-
lar to that of mock-infected cells when tested at 6–8 and
20 h.p.i. (Figure 2B and Supplementary Figure S2c). VP16-
GFP was poorly affected by PAA and ACV at 6–8 h.p.i.; at
20 h.p.i. it localized prevalently in the nucleus, due to the
reported compound interference with L viral proteins (39)
(Figure 2B and Supplementary Figure S2c).
To check if G4s formedwithin the cell as a response to the
viral infection, cells were infected with an unrelated virus,
i.e. the human immunodeficiency virus HIV-1, and visu-
alized for G4s with 1H6 Ab. HIV-1 has a much shorter
genome compared to HSV-1 (around 9,000 versus 150,000
nt) and it has been shown to form only few G4s in key re-
gions of the genome (six confirmedG4s inHIV-1 versus 67–
70 G4 repeats in HSV-1) (13,15,17), even if more putative
G4 sequences are present in both viruses. In addition, only
few copies of the HIV-1 DNA genome integrate into each
host cell chromosome (40). Therefore, HIV-1 while impos-
ing to the cell a stress typical of virus infection, does not
display G4s andDNA replication rate as high as HSV-1. In-
fection of cells at differentMOIs of HIV-1 showed no virus-
dependent increase in G4s (Supplementary Figure S6): a
statistically significant decrease was observed only at MOI
2, effect likely due to the virus-dependent cytotoxicity at this
MOI which largely decreased the number of cells (Supple-
mentary Figure S6).
These data altogether suggest that HSV-1 G4s are mainly
responsible for the increased G4 signal in HSV-1 infected
cells during viral replication.
G4s localize in virus replication compartments in infected
cells
To detect if the G4s observed in infected cells localized in
virus-related compartments within the cell, an anti-ICP8
antibody was used. ICP8 is a DNA binding viral protein re-
quired for formation of viral pre-replication and replication
compartments (RCs) (41–44). Cells infected with wt HSV-
1 were co-stained at 6–8 h.p.i. with anti-ICP8 and anti-G4
(1H6) antibodies: the ICP8 protein localized in the cell nu-
cleus, as previously reported (22) and an extended G4/RC
colocalization was appreciable in the 2D images (Supple-
mentary Figure S7). Accurate 3D analysis of several cells
confirmed the presence of multiple overlapping foci of G4s
and RCs at the internal layer of the nuclear membrane and
distributed in the cell nucleus (yellow/orange signal, Fig-
ure 4A). In contrast, the most intense regions stained by
the DNA probe DRAQ5®, reasonably corresponding to
the cell chromosome DNA, were particularly poor in G4s
and RCs (white arrows, Figure 4A). The observed degree of
colocalization was further confirmed by the intensity pro-
files acquired in the 3D single-cell along an ideal arrow en-
tirely sectioning the cell nucleus: the G4 and RC signals
displayed overlapping profiles (red and green lines, respec-
tively, Figure 4B), whereas they were distinct from the cell
DNAprofile (blue line, Figure 4B). The Pearson correlation
coefficient (PCC) (45), which is 1 in an ideal 100% overlap-
ping, was 0.89. As negative control, the same analysis was
performed in the nucleus of a cell stained with VP16-GFP
and 1H6, the signals of which were not expected to overlap.
Indeed, intensity profiles did not overlap and PCC corre-
sponded to 0.14 (Supplementary Figure S8).
To further assess G4 localization, immune-EM was per-
formed on cells infected with wt HSV-1, fixed at 8 and 15
h.p.i. and incubated with anti-G4 and anti-ICP8 serum,
conjugated to 5- and 10-nm gold particles, respectively (Fig-
ure 5A-C’). At both times p.i., G4s and ICP8 were mostly
found in close proximity; samples obtained at 15 h.p.i. were
the most informative since at this time p.i. premature cap-
sids ready for budding from the nuclear membrane begin to
be visible. Indeed, G4s and ICP8 were detected in clusters
close to the nuclear membrane, in which nuclear pores (Fig-
ure 5A-A’) were observed. Indeed nuclear egress has been
reported to follow diverse pathways: budding of capsids at
the inner nuclear membrane into the perinuclear space or
via rough endoplasmic reticulum (RER) into Golgi cister-
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Figure 3. Quantification of G4s in HSV-1 infected cells by flow cytometry. (A) Analysis of the increase of 1H6 fluorescence in HSV-1 infected cells (in
red) in comparison with mock-infected cells (in black) as indicated by the red arrow. No effect on fluorescence was observed in the presence of the Alexa
Fluor-633 secondary antibody only (Alx633) in neither mock-infected nor infected cells (see histogram on the left, curves are indicated in blue and green
respectively). Figures are representative of two independent experiments, each made in triplicate. (B) Mean of 1H6 fluorescence in mock-infected and
infected cells: a 57% increase, in terms of mean of 1H6 fluorescence was observed in infected cells compared to mock-infected cells within the replication
time range. The mean of Alx633 in mock-infected and infected cells resulted superimposable and no increase was observed.
nae, or direct access from the nucleus to the cytoplasm via
nuclear pores (46,47). G4s and ICP8 were clearly assem-
bled also in particularly crowded viral RCs producing many
capsids in proximity to the nuclear membrane (Figure 5B-
B’) (35,36,48). In several cases G4s were observed within
the core of immature capsids, which enclose viral DNA. In
particular, capsids in the nucleoplasm, before and after fu-
sion at the nuclear membrane and in the perinuclear RER
(Figure 5B-C’ and Supplementary Figure S9) were found to
contain G4s. The amount and distribution of G4s in mock-
infected cells was distinctly different from those in HSV-
1 infected cells: a lower number of G4s were detected in
the cell nucleus and mostly not close to the nuclear mem-
brane (Supplementary Figure S10, panels a–d). The pres-
ence of G4s was negligible in HSV-1 infected cells lacking
treatment with anti-G4 and anti-ICP8 Abs (Supplementary
Figure S10, panels e and f). These data were statistically an-
alyzed by quantification of G4s and ICP8, performed by
counting the number of 5 nm (red, G4) and 10 nm (green,
ICP8) dots in all samples (Figure 5D). About 35–45 images
per sample were considered and data were reported as the
number of dots per mm2. In nuclear areas close to the nu-
clear membrane, the highest concentration of both G4s and
ICP8 was observed (9.8 and 10.5 dots/mm2, respectively).
Other nuclear areas that displayed a lower density of G4
dots (≤5 dots/mm2) were calculated separately. In this case
a less marked correlation between G4s and ICP8 was ob-
served (4.5 and 3 dots/mm2, respectively). To note that the
lower density areas represented only 14.7% of all tested ar-
eas. Themock-infected samples displayed 3.3G4 dots/mm2
and no ICP8was detected; infected andmock-infected sam-
ples lacking treated with the primary Abs showed very low
amount of unspecific labeling (Figure 5D). The number of
G4s in capsids (Figure 5B-C’ and Supplementary Figure
S9) was low but statistically significant (0.23/capsid, P <
0.01), whereas no specific signal in virions was found in
infected cells treated with only the secondary Ab. These
data altogether indicate that G4s visualized in infected cells
are present in virus-related compartments (RCs and newly
formed virions) and thus strongly support the presence of
G4s in the viral genome during the HSV-1 infective cycle.
DISCUSSION
We showed here that HSV-1 infected cells were highly en-
riched inG4s. In particular, the amount ofG4s depended on
the virus amount (MOI) and on the viral step, being more
intense around the time of viral DNA replication. This find-
ing is in line with the reported presence of G4s in the duplex
DNA in the eukaryotic genome during events that promote
dissociation of the G-rich strand from its complementary
strand (49), i.e. during transcription (50), replication (51),
DNA repair (52) or under molecular crowded conditions
(53).
Besides G4s forming in the viral genome, the enrichment
ofG4s duringHSV-1 infectionmight also derive from virus-
induced manipulation of host cell factors (54). Indeed, a
number of DNA viruses, which require cellular DNA repli-
cation proteins for viral replication (i.e. adenovirus, simian
virus 40 and human papillomavirus), encode functions to
promote cellular S phase. However, this is not the case of
HSV-1, which encodes a large number of genes associated
with its DNA synthesis (55,56); in fact, HSV-1 infection re-
sults in the activation of only a limited number of cellular
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Figure 4. Colocalization of G4s and the viral protein ICP8 by 3D con-
focal microscopy. ICP8 is a marker for HSV-1 replication compartments
(RCs) (41). (A) Cells were infected with different amounts of wt HSV-1
(strain F), MOI 2.5 (upper panel) and 5 (lower panel). At 6–8 h.p.i. cells
were stained with the anti-G4 (1H6) and anti-ICP8-FITC Abs. Blue, red
and green indicate DNA, G4s and ICP8-dependent viral RCs, respectively.
The images on the right (merge) show G4 (red) and ICP8 (green) overlap-
ping as a yellow/orange signal. Spatial orientation is indicated. (B) Inten-
sity profiles of DNA (blue), G4s (red) and ICP8-dependent RCs (green)
obtained with NIS-Elements Advanced Research software, along an ideal
24 m-long straight line (white) crossing the nucleus of a representative
infected cell (right inset). The DNA profile defines the nuclear area where
the G4 and ICP8 profiles are clearly also enclosed. G4 and ICP8 exhibit
very similar fluorescence profile. The scale bar is set to 10 m.
promoters contained in the cellular genome (57) and it is
rather linked to inhibition of cellular DNA synthesis asso-
ciated with cell cycle arrest in G1/S (44). In addition, we
have shown that HIV-1 does not modify the number of G4s
in the infected cell.
Confocal microscopy colocalization analysis in our study
showed an almost complete overlapping between G4s in-
duced during the viral infection and RCs where ICP8, an
essential component of the HSV-1 DNA replication ma-
chinery implicated in the assembly of viral pre-replication
and RCs (41–44), localized. This evidence supports forma-
tion of viral G4s during viral replication. ICP8 has been re-
cently shown to co-localize with telomeric foci (58) in the
cell nucleus, however, no G4 dependence has been reported:
it is thus unlikely that colocalization signals obtained in
our experiments derive from telomeric G4s/ICP8 colocal-
ization. Moreover, G4s in infected cells were much more
abundant than those in mock-infected cells and their local-
ization within the nucleus at different times p.i. moved in a
pattern compatible with the processing of viral DNA dur-
ing the virus cycle. In particular, G4s were distributed in foci
corresponding toRCs all over the nucleus during viralDNA
replication (6 h.p.i.) (43,44,59–61), while they clustered at
the nuclear membrane at later times (14 h.p.i.), when late
maturation of viral RCs (i.e. replication, late-gene transcrip-
tion and encapsidation) takes place (36,38).
Interestingly, immune-EM analysis allowed to detect G4s
in immature virions before and after budding from the nu-
clear membrane (Figure 5). In the virions the viral genome
is linear and double-stranded and no replication events oc-
cur. The presence of G4s at this level is compatible with the
reported induction of G4s under molecular crowded condi-
tions (53) and with the recently provided evidence that G4s
are also present in post-mitotic DNA (21).
Attempts to characterize the DNA enriched for 1H6
binding sites have thus far been unsuccessful (8,21), how-
ever, since (i) the HSV-1 genome is extremely rich in G-rich
regions that fold in G4 in vitro (17); (ii) a G4 ligand was
able to suppress viral DNA replication and infectivity (17);
(iii) ACV and PAA, compounds that selectively inhibit the
viral DNA polymerase, decrease the amount of G4s in the
infected cell (shown here); (iv) G4s in infected cells show
striking virus cycle- and virus amount-dependence (shown
here); (v) G4s in infected cells associate with viral RCs and
are present in immature virions before and after budding at
the nuclear membrane (shown here) convincingly indicate
that the observed G4s are viral structures.
In latently infected neurons in vivo, an average of 20–50
genome copies, with peaks up to 900 genome copies per cell,
have been measured (62). During the in vivo outburst of
the lytic infection, almost 10,000 HSV genome copies per
cell have been estimated to be produced before cells were
eliminated by CD8+ T cell-mediated response (63). In vitro,
the number of new genome copies depends on the initial
amount of the infecting virus (MOI), as shown in Figure 2B,
C and Supplementary Figure S2b; given that no limitation
from the immune system of the host is present in our cell
system in vitro, an even higher amount of HSV-1 genomes
per cell may be expected. In each HSV-1 genome we have
confirmed 67–70 G4 repeats, however, other isolated G4s
are also present (17).With these figures, the number of HSV
G4s that form in a limited range of time in vitro may reach
very high levels per cell, numbers that justify the extensive
G4 signal that we observed.
The viral G4 massive presence during the viral cycle sug-
gests a key epigenetic role played by these structures dur-
ing the viral replication cycle and points to possible new ac-
tors in the viral biology. For instance, one G4 repeat is em-
bedded in the promoter of one key protein responsible for
in vivo HSV-1 neurovirulence and induction of autophagy
(17,64); almost all G4 repeats are in the terminal repeats of
the HSV-1 genome, the functions of which are not yet fully
understood. It is possible that the interaction of G4s with
key factors in the initial steps of virus replication regulates
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Figure 5. Immuno-EM of HSV-1 infected cells, fixed at 15 h.p.i. and incubated with anti-G4 Ab (1H6) and 3–83 anti-ICP8 serum. Primary 1H6 and anti-
ICP8 Abs were detected with 5- and 10-nm gold particles, respectively. To improve image clarity, gold particles were highlighted with red dots (indicating
G4s) and green encircled white dots (indicating ICP8) in A, B, C. The original images are provided in the corresponding panels A’, B’, C’. (A-A’) G4s and
ICP8 are gathered in close proximity to the nuclear membrane (NM) where a nuclear pore complex (NPC) is present. Nuclear egress via NCP is one of the
pathways used by HSV-1 capsids to move from the nucleus (n) to the cytoplasm (cyt) (46,47); (B-B’) G4s and ICP8 clustered close to the NM, where many
newly formed virions are budding. (C-C’) After nuclear egress, enveloped virions, some of which show the presence of G4s in their core, are transported into
RER. ‘n’ indicates the nucleoplasm, cyt the cytoplasm. Bars length is indicated in each panel. Panel (D): statistical analysis of G4 and ICP8 distribution in
cells. G4 and ICP8 dots were calculated in 35–45 images per each condition and represented as dot/mm2. Cell areas with ≤5 dots/mm2 were considered
low-density (LD) areas and calculated separately with respect to high-density (HD) areas. Cnt are infected cells treated only with secondary Abs. MI are
mock-infected cells treated with both the primary and secondary Abs; MI cnt are mock-infected cells treated only with the secondary Abs. In all data sets:
mean ± sem, Student’s t-test, *P < 0.05, **P < 0.01.
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the virus cycle itself. These new mechanistic insights may
support the design of innovative anti-HSV-1 drugs. While
ACV has been the antiviral drug of choice for the treatment
of HSV-1 infections (65) since its first introduction in the
1980s, the emergence of resistance to ACV has created an
obstacle for the treatment of HSV-1 (66). Because of the in-
herent different mechanism of action, G4 ligands could be
envisaged as therapeutic options against HSV-1 strains re-
sistant to current anti-herpetic drugs. In this direction, we
have recently shown the availability of small molecules that
target the HIV-1 G4s with a degree of selectivity vs the cel-
lular telomeric G4s, resulting in very good antiviral proper-
ties (67). These data indicate the possibility to identify lig-
ands selective for HSV-1 G4s. In addition, the overwhelm-
ing presence of viral G4s during replication, as indicated in
this work, could also be exploited to develop antiviral com-
pounds even when they do not display outstanding selec-
tive recognition properties against HSV-1 G4s. Indeed, we
have already reported that BRACO-19, a G4 ligand lacking
selectivity against viral G4s, displays good anti-HSV-1 ac-
tivity (17). Moreover, the HSV-1 genome is responsible for
both the lytic and latent infection, the latter lasting for the
entire life of the human host: the availability of targets in the
viral genome may also pave the way for the development of
drugs able to eradicate the virus.
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